Coronavirus Disease 2019 in Lung Transplant Recipients.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33347850.
- Also identified by DOI 10.1016/j.athoracsur.2020.11.032 and PMC identifier 7836729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report risk factors, clinical manifestations, and treatment course of 2 lung transplant recipients diagnosed with coronavirus disease 2019 (COVID-19) pneumonia. Both patients underwent an initial hospitalization and discharged home, followed by readmission several days later with significant worsening of respiratory status and infectious symptoms. The first patient underwent prolonged hospitalization requiring tracheostomy and feeding tube placement. The second patient declined intubation and expired. The early documented experiences of COVID-19 pneumonia in lung transplant recipients suggest that although recovery is achievable, the high rate of comorbid conditions and immunocompromised state may place these patients at higher risk for poor outcomes.
Medical subject headings
- COVID-19
- Immunocompromised Host
- Immunosuppressive Agents
- Lung Diseases
- Lung Transplantation